Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2020Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: An observational cohort study
Behrens, F.; Tony, H.-P.; Koehm, M.; Schwaneck, E.C.; Gnann, H.; Greger, G.; Burkhardt, H.; Schmalzing, M.
Zeitschriftenaufsatz
2020Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy?
Schmalzing, M.; Behrens, F.; Schwaneck, E.C.; Koehm, M.; Greger, G.; Gnann, H.; Burkhardt, H.; Tony, H.-P.
Zeitschriftenaufsatz
2020Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: An observational cohort study
Behrens, F.; Tony, H.-P.; Koehm, M.; Schwaneck, E.C.; Gnann, H.; Greger, G.; Burkhardt, H.; Schmalzing, M.
Zeitschriftenaufsatz
2019Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Wittig, B.M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Zeitschriftenaufsatz
2019Characterization Of Patients With Inflammatory Bowel Disease In The Ankylosing Spondylitis Cohort Prior And During Adalimumab Treatment: Data From A Large German Non-Interventional Study
Köhm, M.; Schmalzing, M.; Schwaneck, E.C.; Gnann, H.; Tony, H.P.; Greger, G.; Boas, A.; Burkhardt, H.; Behrens, F.
Abstract
2018Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Zeitschriftenaufsatz
2016Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis
Behrens, F.; Koehm, M.; Thaci, D.; Gnann, H.; Greger, G.; Wittig, B.M.; Burkhardt, H.
Zeitschriftenaufsatz
2016Association of Improvement in Pain with Therapeutic Response as Determined by Individual Improvement Criteria in Patients with Rheumatoid Arthritis
Scharbatke, E.C.; Behrens, F.; Schmalzing, M.; Koehm, M.; Greger, G.; Gnann, H.; Burkhardt, H.; Tony, H.-P.
Zeitschriftenaufsatz
2016Characterization of Ra patients with a DAS28 response to adalimumab therapy by improvement in pain: A german nonintervention study
Köhm, M.; Scharbatke, E.; Stemmler, E.; Greger, G.; Behrens, F.; Wittig, B.
Abstract
2016Does concomitant methotrexate with adalimumab influence treatment outcomes in patients with psoriatic arthritis? Data from a large observational study
Behrens, F.; Koehm, M.; Arndt, U.; Wittig, B.M.; Greger, G.; Thaci, D.; Scharbatke, E.; Tony, H.-P.; Burkhardt, H.
Zeitschriftenaufsatz
2016Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment with Adalimumab
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Abstract
2015 Association between Skin and Joint Involvement in Patients with Psoriatic Arthritis Treated with Adalimumab: Analysis of Data from a German Non-Interventional Study
Thaci, D.; Behrens, F.; Greger, G.; Burkhardt, H.; Gnann, H.; Schopf, R.; Wittig, B.M.
Zeitschriftenaufsatz
2015The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
Feuchtenberger, M.; Kleinert, S.; Scharbatke, E.C.; Gnann, H.; Behrends, F.; Wittig, B.M.; Greger, G.; Tony, H.P.
Zeitschriftenaufsatz
2015Predictors of therapeutic response in ankylosing spondylitis patients initiating therapy with adalimumab in a german non-interventional study
Koehm, M.; Behrens, F.; Scharbatke, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Wittig, B.; Tony, H.P.; Burkhardt, H.
Abstract
2015SAT0070 Association of Improvement in Pain with Therapeutic Response as Determined by Individual Significant Improvement Criteria in Patients with Rheumatoid Arthritis
Scharbatke, E.; Behrens, F.; Schmalzing, M.; Koehm, M.; Greger, G.; Gnann, H.; Tony, H.P.; Burkhardt, H.
Abstract
2014Effects of methotrexate on anti-TNF treatment in rheumatoid arthritis
Schmalzing, M.; Behrens, F.; Scharbatke, E.C.; Koehm, M.; Wittig, B.; Greger, G.; Burkhardt, H.; Tony, H.P.
Abstract
2014SAT0358 impact of methotrexate on anti-TNF treatment in psoriatic arthritis? An in-depth analysis of a large prospective observational study with adalimumab
Behrens, F.; Köhm, M.; Arndt, U.; Wittig, B.; Greger, G.; Thaci, D.; Scharbatke, E.; Tony, H.P.; Burkhardt, H.
Abstract
2013Development and validation of a new disease activity score in 28 joints–based treatment response criterion for rheumatoid arthritis
Behrens, F.; Tony, H.-P.; Alten, R.; Kleinert, S.; Scharbatke, E.C.; Köhm, M.; Gnann, H.; Tams, J.; Greger, G.; Burkhardt, H.
Zeitschriftenaufsatz
2013DMARD-Versager vs. TNF-Versager bei aktiver Psoriasis-Arthritis: Vergleichende Untersuchung zu Krankheitscharakteristika aus einer großen prospektiven Observationsstudie vor Einleitung einer Therapie mit Adalimumab
Behrens, F.; Köhm, M.; Thaci, D.; Krummel-Lorenz, B.; Greger, G.; Wittig, B.; Burkhardt, H.
Abstract
2013Gibt es eine Assoziation zwischen Haut- und Gelenkmanifestation bei Patienten mit Psoriasis-Arthritis? – Datenanalyse einer deutschen nichtinterventionellen Studie mit Adalimumab bei aktiver Psoriasis-Arthritis
Köhm, M.; Behrens, F.; Thaci, D.; Krummel-Lorenz, B.; Greger, G.; Wittig, B.; Burkhardt, H.
Abstract
2013Wirksamkeit von Adalimumab bei aktiver Psoriasis-Arthritis und unzureichendem Ansprechen auf bis zu drei Anti-TNF-Vortherapien
Köhm, M.; Behrens, F.; Thaci, D.; Krummel-Lorenz, B.; Greger, G.; Wittig, B.; Burkhardt, H.
Abstract